Biomaterials startup Zentraxa announce seed investment

Our member company and University of Bristol spin-out, Zentraxa, has raised capital investment from Future Planet Capital, BPEC and Science Angel Syndicate to develop their innovative Zentide platform for engineering bespoke biomaterials. With generous support of their recently awarded Innovate UK grant, Zentraxa is rapidly moving towards contracted commercial concept development in both medical adhesives…

Read More

FluoretiQ announces the closure of £1.1 million funding round

Our member and University of Bristol spin-out, FluoretiQ, has today announced the completion of a £1.1 million, pre-series A investment. Their pioneering NANOPLEX technology is a 15-minute proprietary diagnostic platform for bacterial infections.   The round was led by early-stage life science investors, Deepbridge Capital LLP, with significant participation from MAINStream, OION, SAIC and existing investors. This…

Read More

FluoretiQ case study: Revolutionising bacterial diagnostics

To help our aspiring entrepreneurs and future SETsquared Bristol members, we showcase member and alumni case studies demonstrating the breadth of tech at SETsquared Bristol and what it takes to achieve success. We had a chat with FluoretiQ Co-founder and CEO, Neciah Dorh… FluoretiQ Key Facts Start date: 2 March 2017 Market sector: Healthcare (Diagnostics) Location:  Bristol Number of employees: 10…

Read More

Airway Medical complete first working prototype

Our member, Airway Medical, in collaboration with the University of Portsmouth and Versarien PLC have announced the conclusion of their project to further the development of The AMSU™ – a novel airway suction device that will soon be helping to save the lives of patients with blocked airways and improving the well-being of people with…

Read More

GenomeKey case study: Saving lives through early diagnosis of sepsis

To help our aspiring entrepreneurs and future SETsquared Bristol members, we showcase member and alumni case studies demonstrating the breadth of tech at SETsquared Bristol and what it takes to achieve success. We had a chat with GenomeKey CEO, Michael Roberts… GenomeKey Facts Start date:  August 2019 Market sector: Medtech/diagnostics Location: Bristol Number of employees: 9 growing to 12 and beyond Amount…

Read More

Latest financing for Micrima developing a disruptive breast cancer scanning system

SETsquared Bristol alumnus, Micrima limited, have closed the latest fundraising round by way of a convertible loan note. The company raised £1.9 million from new and existing shareholders which is being matched by the ‘Future Fund’, the UK government initiative delivered by the British Business Bank, thereby providing Micrima with £3.8 million of funding in…

Read More

Bristol Medtech company wins Innovate UK grant for clearing blocked airways in emergency and chronic conditions

SETsquared Bristol member, Airway Medical, based at the Engine Shed near Temple Meads station in Bristol, today announced that they have been awarded funding from The Sustainable Innovation Fund from UK Government funding agency Innovate UK. Innovate UK as part of UK Research and Innovation, is investing up to £191 million to fund both single…

Read More